Instil Bio, Inc. cotiza a 6.18 USD y tiene una capitalización bursátil de $42M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, …
| Periodo | 2026-05 | 2026-03 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.62 | $-0.97 | — | $-2.01 |
| Estimado | $-0.59 | $-3.78 | $-3.78 | $-2.35 |
| Sorpresa | -5.1% | +74.3% | — | +14.5% |
| Métrica | TIL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -62.7% | -40.4% | -22.3% |
| ROA | -35.1% | -32.0% | -3.1% |
| Current Ratio | 39.53 | 2.84 | +36.69 |
| Debt / Equity | — | 0.28 | — |